相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploration of the immune cell infiltration-related gene signature in the prognosis of melanoma
Yangyang Zeng et al.
AGING-US (2021)
ARID2 Deficiency Correlates with the Response to Immune Blockade in Melanoma
Takeshi Fukumoto et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)
Predictive role of microsatellite instability for PD-1 blockade in patients with advanced gastric cancer: a meta-analysis of randomized clinical trials
F. Pietrantonio et al.
ESMO OPEN (2021)
Immunotherapy for advanced melanoma: current situation in Japan
Junji Kato et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2021)
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation-positive melanoma receiving adjuvant vemurafenib
P. A. Ascierto et al.
ANNALS OF ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Fabienne Maibach et al.
FRONTIERS IN IMMUNOLOGY (2020)
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Robert Ballotti et al.
MOLECULAR CANCER (2020)
Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy
Xinhai Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
Yoshiyuki Nakamura et al.
FRONTIERS IN ONCOLOGY (2020)
MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma
Ricardo A. de Azevedo et al.
ONCOIMMUNOLOGY (2020)
Prognostic Role of Tumor Mutation Burden Combined With Immune Infiltrates in Skin Cutaneous Melanoma Based on Multi-Omics Analysis
Junya Yan et al.
FRONTIERS IN ONCOLOGY (2020)
Tumor MHC Expression Guides First-Line Immunotherapy Selection in Melanoma
Elena Shklovskaya et al.
CANCERS (2020)
Comprehensive Analysis of the Tumor Microenvironment in Cutaneous Melanoma associated with Immune Infiltration
Pan Wang et al.
JOURNAL OF CANCER (2020)
PCA-based GRS analysis enhances the effectiveness for genetic correlation detection
Yan Zhao et al.
BRIEFINGS IN BIOINFORMATICS (2019)
Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma
Joanna Pozniak et al.
CANCER RESEARCH (2019)
Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
Monica Marzagalli et al.
SEMINARS IN CANCER BIOLOGY (2019)
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T. A. Chan et al.
ANNALS OF ONCOLOGY (2019)
PD-L1 expression and tumor mutational burden are independent biomarkers in most cancers
Mark Yarchoan et al.
JCI INSIGHT (2019)
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial
Thomas Powles et al.
LANCET (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Primary and Acquired Resistance to Immune Checkpoint Inhibitors in Metastatic Melanoma
Tuba N. Gide et al.
CLINICAL CANCER RESEARCH (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Elements of cancer immunity and the cancer-immune set point
Daniel S. Chen et al.
NATURE (2017)
Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
Nayoung Lee et al.
PATHOLOGY (2016)
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan et al.
SCIENCE (2016)
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
Cyrille J. Cohen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment
Thomas F. Gajewski
SEMINARS IN ONCOLOGY (2015)
Biology of advanced uveal melanoma and next steps for clinical therapeutics
Jason J. Luke et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment
Chiara Camisaschi et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
Update on primary mucosal melanoma
Joselin D. Tacastacas et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register
J. Lyth et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Cancer immunotherapy strategies based on overcoming barriers within the tumor microenvironment
Thomas F. Gajewski et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Tumor-Infiltrating Lymphocyte Grade in Primary Melanomas Is Independently Associated With Melanoma-Specific Survival in the Population-Based Genes, Environment and Melanoma Study
Nancy E. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Prognostic Importance of the Extent of Ulceration in Patients With Clinically Localized Cutaneous Melanoma
Florentien E. M. in't Hout et al.
ANNALS OF SURGERY (2012)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Gene expression profiling in breast cancer: Understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
分享论文
